What is Procysbi in Australia (and what is it used for)?
Procysbi is the brand name for delayed-release cysteamine (cysteamine bitartrate), a medicine used to treat nephropathic cystinosis. It helps lower cystine accumulation in the body, including in the kidneys. Procysbi is supplied as oral capsules [1].
Is Procysbi available in Australia? (TGA listing and access)
To confirm whether Procysbi is currently available for prescription in Australia, you typically check the Australian Register of Therapeutic Goods (ARTG) via the TGA website. The exact availability, prescribing rules, and whether it is restricted or subsidised can depend on the current TGA listing status and medicine supply/dispensing arrangements [1].
How do patients get it in practice (scripts, special access, substitution)?
Access in Australia usually works through a prescription from a specialist or treating clinician. If a product is not routinely available through normal dispensing or PBS channels, doctors may request an alternative access pathway (for example, via special access arrangements or specific prescribing pathways) depending on the medicine’s regulatory and supply status [1].
Who should be prescribed Procysbi and who monitors treatment?
Treatment is generally managed by clinicians experienced with cystinosis. Monitoring commonly includes kidney function and cystine-related outcomes, because the medicine’s goal is to slow organ damage over time. Your specialist will set the dosing schedule and monitoring plan based on your age and disease status.
What patients ask about most: dosing timing and missing doses
Procysbi is a delayed-release formulation, so correct timing with daily routines matters. If you miss a dose, the usual next-step advice depends on how late the dose was missed and your prescriber’s instructions (so the safest guidance is to follow the consumer medicine information and your specialist’s plan).
Side effects and safety concerns people look up
Patients often want to know about common gastrointestinal effects and other tolerability issues that can occur with cysteamine medicines. For exact side-effect frequencies and what to do if they occur, the most reliable source is the product information/consumer medicines information for Procysbi in Australia [1].
What is the cost/subsidy situation in Australia (PBS and alternatives)?
Whether Procysbi is listed for subsidised prescribing (PBS) in Australia depends on the current PBS listing. If it is not subsidised for your category of use, out-of-pocket costs can be significant. If you want, tell me whether you’re asking about adults or children and whether you have private or public insurance/PBS access, and I can help you narrow down what to check.
Where to verify the latest Australian details
The most direct sources for Australia-specific availability and prescribing details are:
- TGA medicines information and ARTG listing for Procysbi [1]
If you share what you need most (availability, cost/PBS, how to get a script, or side effects), I can tailor the answer to that.
---
Sources:
[1] https://www.tga.gov.au/resources/resource/arthur?title=Procysbi